Oracle (ORCL) March 114 straddle into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Wall St set for higher open as SpaceX, Super Micro results rekindle AI trade
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Abbott plans to spin off its nutrition unit as a standalone public company
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- Anthropic logged net loss of over $80 billion in first half of 2026
Oracle (ORCL) PT Raised to $142 at CFRA
March 12, 2024 9:30 AM EDTCFRA analyst Angelo Zino raised the price target on Oracle (NYSE: ORCL) to $142.00 (from $130.00) while maintaining a Hold rating.
The analyst comments "We increase our 12-month target to $142 from $130, on a higher revised P/E of 21x our CY 25 EPS estimate of... More
Oracle (ORCL) PT Raised to $145 at TD Cowen
March 12, 2024 6:39 AM EDTTD Cowen analyst Derrick Wood raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "ORCL reported a solid 3Q w/ total rev growth of 7% cc in line w/ guide of 6-8%, incl.... More
Oracle (ORCL) PT Raised to $145 at Evercore ISI, 'Outlook Less Cloudy'
March 12, 2024 5:02 AM EDTEvercore ISI analyst Kirk Materne raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "Bottom line: Oracle shares are up nicely in the after-market as OCI revenue growth of 52% in c/c was in line with our expectations and importantly, F4Q guidance infers OCI growth of ~40% against a very difficult compare. The other highlight was the strength in RPO, which grew 41% in c/c excl. Cerner to $80bn and cRPO growth of ~15%. Notably, OCI revenue grew $175mn sequentially vs. $100mn last quarter.... More
Oracle (ORCL) PT Raised to $150 at Jefferies, 'F3Q: Base Hit, One Runner On'
March 12, 2024 5:01 AM EDTJefferies analyst Brent Thill raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $145.00) while maintaining a Buy rating.
The analyst comments "ORCL made contact in F3Q after a disappointing F1H led by better-than-expected OCI results and 29% backlog growth. While... More



